News and Research
ACART is seeking your feedback
Currently women in New Zealand can cryopreserve and store ovarian tissue, but are unable to use it in New Zealand. ACART has reviewed recent evidence and considered the risks, benefits and ethical issues associated with the use of cryopreserved ovarian tissue to restore ovarian function. ACART is proposing that the use of cryopreserved ovarian tissue to restore ovarian function should become an established procedure.
Comments:
You must be logged in to leave a reply. Login »